Table: begin end state 1 6 cytoplasmic 7 31 transmembrane 32 54 non-cytoplasmic 55 89 transmembrane 90 100 cytoplasmic 101 124 transmembrane 125 146 non-cytoplasmic 147 177 transmembrane 178 188 cytoplasmic 189 216 transmembrane 217 224 non-cytoplasmic 225 245 transmembrane 246 270 cytoplasmic 271 291 transmembrane 292 296 non-cytoplasmic 297 314 transmembrane 315 333 cytoplasmic 334 352 transmembrane 353 362 non-cytoplasmic 363 384 transmembrane 385 389 cytoplasmic 390 410 transmembrane 411 424 non-cytoplasmic 425 450 transmembrane 451 469 cytoplasmic 470 493 transmembrane 494 499 non-cytoplasmic
Input: >GFF3083 MAGKLGTWLMIIATVGLAFVICVELINILFYDPWSDEKFLFKLSGSLSGVEIGPLTYLMF GSLAVALMMGLPLAFVTGGLGVMFIYLVGDAMMLNIVPGRIFPLMANPDIAAIPLFIFMA SMLERAGLIEEMFSVVYKWMGGISGGLAAATIVASTILAAMVGVIGAAVVTMGIIALPAM LKRHYDHKIAIGSIMAGGTLGILIPPSILAILYAVVAQQSVGELYLGSLLPGLMLSGLYL TYVLVRSWLNPKLGPPIPVEDRISLKEKLKLLGNLIAPLALVGLVLGLLFGGIATPVEAA GIGSFGAIIVAMMHKKFSIAGLREASVTTAKASAMVLWIMFGASVFVGFYILQGGQQFVT DAILGTGMSAYGILFLLMVLLVVLGMFLDWVGILLLAVPIFIPIVKALEFPGLFGFPPVA GDDVVLWFGVLYLVNMQMSFLSPPFGYALFYIRGVCPPEISMGTIFKSSLVFLAIQAFGL FMCVLIPGIVTWLPGLVYG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server